Cargando…

Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine, historical cohort study' by Shasha et al

Detalles Bibliográficos
Autores principales: Scorza, Fulvio Alexandre, Finsterer, Josef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613931/
https://www.ncbi.nlm.nih.gov/pubmed/34839005
http://dx.doi.org/10.1016/j.cmi.2021.11.013
_version_ 1784603749337006080
author Scorza, Fulvio Alexandre
Finsterer, Josef
author_facet Scorza, Fulvio Alexandre
Finsterer, Josef
author_sort Scorza, Fulvio Alexandre
collection PubMed
description
format Online
Article
Text
id pubmed-8613931
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-86139312021-11-26 Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine, historical cohort study' by Shasha et al Scorza, Fulvio Alexandre Finsterer, Josef Clin Microbiol Infect Letter to the Editor European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022-03 2021-11-25 /pmc/articles/PMC8613931/ /pubmed/34839005 http://dx.doi.org/10.1016/j.cmi.2021.11.013 Text en © 2021 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Scorza, Fulvio Alexandre
Finsterer, Josef
Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine, historical cohort study' by Shasha et al
title Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine, historical cohort study' by Shasha et al
title_full Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine, historical cohort study' by Shasha et al
title_fullStr Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine, historical cohort study' by Shasha et al
title_full_unstemmed Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine, historical cohort study' by Shasha et al
title_short Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine, historical cohort study' by Shasha et al
title_sort real-world safety data for the pfizer bnt162b2 sars-cov-2 vaccine, historical cohort study' by shasha et al
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613931/
https://www.ncbi.nlm.nih.gov/pubmed/34839005
http://dx.doi.org/10.1016/j.cmi.2021.11.013
work_keys_str_mv AT scorzafulvioalexandre realworldsafetydataforthepfizerbnt162b2sarscov2vaccinehistoricalcohortstudybyshashaetal
AT finstererjosef realworldsafetydataforthepfizerbnt162b2sarscov2vaccinehistoricalcohortstudybyshashaetal